JAMA Network Home
Sign In
Research Letter

Access to Chimeric Antigen Receptor T-Cell Therapy in Patients With Diffuse Large B-Cell Lymphoma

JAMA Network Open 10.1001/jamanetworkopen.2025.38602

October 22, 2025 at 11:00 AM EDT

Read the full article

This case-control study evaluates the delay in treating relapsed or refractory diffuse large B-cell lymphoma due to distant access to chimeric antigen receptor T-cell (CAR T) therapy.

Corresponding Author: Anirban Basu, PhD, University of Washington, 1959 NE Pacific St, Box 357631, Seattle, WA 98195 (basua@uw.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2025.38602?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=102225

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks